Company’s AD-Detect portfolio offers AB 42/40 and other plasma biomarker testing, alongside traditional cerebrospinal fluid and genetic tests, to provide robust offering in brain...
The team acknowledges the challenges in realizing this potential, particularly the standardization of urinary biomarker assays and the expansion of the spectrum of diseases that...
The review article, “The Potential of Blood Neurofilament Light as a Marker of Neurodegeneration in Alzheimer’s disease,” is published in the journal Brain.
As laboratory assays have evolved with improved performance, the clinical use of cardiac troponin (cTn) has also evolved beyond the context of myocardial infarction (MI). The ...
Walking up the stairs had become difficult for Louise, an otherwise healthy, active, and stubborn 85-year-old retired nurse. It was spring, and Louise figured that she was deconditioned...
There are approximately 69 million traumatic brain injuries (TBI) in the world every year.1 It is the leading cause of death and long-term disability among all trauma related ...